Effects of Yoga and Cardiovascular Exercise on Smoking Motivation
NCT ID: NCT01423578
Last Updated: 2017-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2007-08-21
2017-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Yoga as a Complementary Therapy for Smoking Cessation
NCT01809678
Yoga for Women Attempting Smoking Cessation
NCT00492310
Examining Yoga's Effects on Smoking
NCT02181179
Effect of Yoga on Reducing Craving in Tobacco Dependent Individuals
NCT06488443
Hatha Yoga for Smoking Cessation
NCT01633632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants will be randomized to receive 3-sessions of yoga instruction, 3-sessions of cardiovascular exercise, or to a no activity control group. Sessions will be scheduled to occur approximately 7 days apart, with a minimum of 4 between sessions. Mood and craving will be assessed before and after each session, and smoking behavior will be assessed following each session. Finally, a detailed cue reactivity assessment will be conducted prior to the first session and following the last session. Analyses will examine intervention effects on craving, mood, cue reactivity, and smoking behavior. In addition, the investigators will examine several potential mediators and moderators of intervention effects on smoking behavior. Finally, the investigators will continue to examine the feasibility and potential acceptability of each active intervention, to assist in developing future clinical applications of these techniques in the context of smoking cessation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hatha Yoga (HY)
Exercise and Smoking Cessation Counseling
Hatha Yoga (HY)
3 Sessions of yoga instruction
Smoking Cessation Counseling
4 smoking cessation counseling visits.
Cardiovascular Exercise (CE)
Exercise and Smoking Cessation Counseling
Cardiovascular Exercise (CE)
3 sessions of cardiovascular exercise
Smoking Cessation Counseling
4 smoking cessation counseling visits.
Smoking Cessation Counseling Only
Control Group - Smoking Cessation Counseling
Smoking Cessation Counseling
4 smoking cessation counseling visits.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hatha Yoga (HY)
3 Sessions of yoga instruction
Cardiovascular Exercise (CE)
3 sessions of cardiovascular exercise
Smoking Cessation Counseling
4 smoking cessation counseling visits.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoked regularly at least 2 years
* Carbon monoxide reading at least 8 ppm
* Interest in quitting smoking
* Able to read and understand the consent form and questionnaires
* Not currently practicing yoga
Exclusion Criteria
* Major depressive episode, manic episode, or panic disorder
* Current DSM-IV psychoactive substance dependence or use
* Current medication use that might affect physiological responses
* Current use of bupropion, varenicline, or nicotine-containing products other than cigarettes
* Significant health problems that might compromise physiological data collection or be contraindicated for moderate physical exercise or yoga
* Significant hearing or visual impairment; pregnant as determined by urine human chorionic gonadotropin (hCG) test or nursing females
* Body mass index (BMI) 35 or greater
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
H. Lee Moffitt Cancer Center and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David J. Drobes, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
H. Lee Moffitt Cancer Center and Research Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCC-15245
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.